Labcorp
926 hedge funds and large institutions have $18B invested in Labcorp in 2024 Q4 according to their latest regulatory filings, with 113 funds opening new positions, 342 increasing their positions, 338 reducing their positions, and 90 closing their positions.
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
26% more first-time investments, than exits
New positions opened: 113 | Existing positions closed: 90
2.31% more ownership
Funds ownership: 91.26% → 93.57% (+2.3%)
5% more capital invested
Capital invested by funds: $17.1B → $18B (+$846M)
1% more repeat investments, than reductions
Existing positions increased: 342 | Existing positions reduced: 338
1% more funds holding
Funds holding: 920 → 926 (+6)
29% less call options, than puts
Call options by funds: $48.5M | Put options by funds: $68.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$297M |
| 2 |
Select Equity Group
New York
|
+$220M |
| 3 |
Amundi
Paris,
France
|
+$200M |
| 4 |
Millennium Management
New York
|
+$122M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$87.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$134M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$121M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$109M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$79.4M |
| 5 |
Barclays
London,
United Kingdom
|
-$75.9M |
LH Hedge Fund Activity: Q4 2024 in Review
926 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q4 2024, worth a combined $18B — up 4.9% from $17.1B a quarter earlier.
Buyers outnumbered sellers: 113 funds opened new LH positions and 90 closed out — a net gain of 23 holders — while 342 added to existing stakes and 338 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $297M. The largest seller was JP Morgan Chase, cutting an estimated $134M.
- 926 institutional investors held Labcorp (LH) as of Q4 2024, up from 920 in Q3 2024.
- Funds reported $18B of Labcorp stock for Q4 2024, up 4.9% quarter-over-quarter.
- 113 funds opened new Labcorp positions in Q4 2024 and 90 closed out, a net change of +23 holders.
- The largest Labcorp buyer in Q4 2024 was Citadel Advisors, an estimated $297M added.
- The largest Labcorp seller in Q4 2024 was JP Morgan Chase, an estimated $134M sold.
Based on aggregated 13F filings for Q4 2024.